Single shot may provide lifelong protection against the flu
A new breakthrough on the cusp of human trials, may mean lifelong protection against the flu.
One flu shot for life?
New flu shot
Valeant beats Street 3Q forecasts
Valeant Pharmaceuticals International Inc. (VRX) on Tuesday reported third-quarter net income of $1.3 billion, after reporting a loss in the same period a year earlier.
Cardinal Health names new CEO as quarterly profit falls 63%
U.S. drug distributor Cardinal Health's quarterly profit fell nearly 63 percent, hurt by restructuring costs related to an agreement to directly distribute surgeon gloves in some markets.
Anthem CEO Joseph Swedish to step down
Health insurer Anthem said on Monday its Chief Executive Joseph Swedish will step down and will be replaced by Gail Boudreaux.
Ryan says health insurance mandate part of GOP tax talks
House Speaker Paul Ryan says Republicans are discussing whether their tax plan should include a repeal of the Obama health law's requirement that people have insurance coverage or face a penalty.
Anthem CEO Joseph Swedish to step down, Gail Boudreaux to succeed: WSJ
U.S. health insurer Anthem Inc's Chief Executive Joseph Swedish will step down and be succeeded by industry veteran Gail Boudreaux, the Wall Street Journal reported on Friday, citing people with knowledge of the matter.
House GOP revises tax bill, makes it less generous
With fanfare and a White House kickoff, House Republicans unfurled a broad tax-overhaul plan that would touch virtually all Americans and the economy's every corner, mingling sharply lower rates for corporations and reduced personal taxes for many with fewer deductions for home-buyers and families with steep medical bills.
BMW issues recalls for fire risk, recommends parking outside
BMW is recalling more than 1.4 million cars and SUVs in two U.S. recalls due to the risk of fires under the hood.
Anthem to withdraw from ObamaCare exchange in Nevada
One of the nation’s largest health insurers, Anthem, announced on Monday it would not offer plans through the ObamaCare exchanges in Nevada next year.
Recalls this week: fire extinguishers, children's clothing
More than 40 million fire extinguishers are being recalled because they can fail to work, potentially resulting in injury or death.
Asia shares muted as investors assess Fed pick, US tax plan
U.S. stocks are slipping Thursday morning as Wall Street waits for news about House Republicans' tax proposals and President Donald Trump's choice for Federal Reserve chair.
Markets Right Now: Stocks closing mixed on Wall Street
The latest on developments in financial markets (All times local): 9:40 a.m.
More than 40M fire extinguishers that may not work recalled
More than 40 million fire extinguishers in the U.S. and Canada are being recalled because they might not work in an emergency.
Cigna's profit tops estimates on higher enrollments
Health insurer Cigna Corp reported a better-than-expected quarterly profit, helped by higher enrollments and strength in its commercial business.
APNewsBreak: Gov't won't pursue talking car mandate
The Trump administration has quietly set aside plans to require new cars to be able to wirelessly talk to each other, auto industry officials said, jeopardizing one of the most promising technologies for preventing traffic deaths.
Edmunds compares Honda Fit and Kia Rio
Driving a small hatchback offers many advantages.
ObamaCare open enrollment begins: What you need to know
The open enrollment period for consumers to buy health care policies on the federal exchanges for the coming year begins Wednesday, though with policy shifts out of D.C., there are changes ahead for companies and individuals.
Business Highlights
___ Trump predicts passage of tax plan by Christmas WASHINGTON (AP) — President Donald Trump is predicting that he will sign his tax overhaul by Christmas in the "biggest tax event in the history of our country."
States seek to expand lawsuit against generic drugmakers
Connecticut's attorney general and 45 of his colleagues are seeking to expand a federal antitrust lawsuit against generic drug-makers to include more manufacturers and medications, as well as senior executives at two companies.













